healthcare topic page on Anadi Algo News

Monday, June 15, 2026
DISCLAIMER: AI-generated signals are for informational purposes only. All trading and investment decisions are solely the user's responsibility.|Past performance does not guarantee future results. Trade at your own risk.|Anadi Algo is not a SEBI-registered advisor. Consult a qualified financial advisor before acting on any recommendation.|DISCLAIMER: AI-generated signals are for informational purposes only. All trading and investment decisions are solely the user's responsibility.|Past performance does not guarantee future results. Trade at your own risk.|Anadi Algo is not a SEBI-registered advisor. Consult a qualified financial advisor before acting on any recommendation.|
AnadiAlgoNews
सट्टा नहीं, सिस्टम
Topic Landing|80 matching stories

healthcare News, Sentiment & Trading Insights

AI-analyzed coverage for the healthcare theme, including latest market stories, signals and related articles.

What Traders Do Next

healthcare is more useful with a process around it.

Use these pages to understand the story first. Execution usually comes later, after the idea is filtered, tested, and sized correctly.

Translate It into Rules

See how a market theme can turn into a structured workflow instead of impulse.

Check the Setup

Use a validation step before any trade decision starts feeling obvious.

Read the Main Algo Guide

Start broad if you want to understand the workflow before you optimize the setup.

This is here if you want to go deeper, not as a push.Explore Anadi
Top Story|et_markets22 days ago

Why India’s next real estate cycle could be driven by retail investors and REITs, Sandipan Roy explains

The real estate sector is poised for a structural shift with new funding dynamics. This could lead to sustained growth and re-rating of real estate stocks and REITs.

buy
Bullish+7590%
Real EstateFinancial Services
+75

Impact Score

Affected Stocks

DLFDLF Ltd
Positive
PHOENIXLTDThe Phoenix Mills Ltd
Positive
MINDSPACEMindspace Business Parks REIT
Positive
EMBASSYEmbassy Office Parks REIT
Positive
BROOKFIELDBrookfield India Real Estate Trust
Positive

+1 more stocks

Consider long positions in well-managed real estate developers and listed REITs, with a focus on companies with strong asset portfolios in the identified growth areas.
et_markets22 days ago

Ahead of Market: 10 things that will decide stock market action on Monday

The pharma sector, despite recent rallies (as per online context), showed weakness on Friday, indicating potential profit-booking or specific concerns. Financials, however, continue to show resilience, suggesting underlying strength in the banking and NBFC space.

Neutral+4085%
5 facts
For financials, look for continuation patterns on Monday; for pharma, exercise caution and monitor for signs of reversal or further weakness, with strict stop-losses.
et_markets22 days ago

6 pharma stocks that Bernstein sees up to 40% upside potential. Do you own any?

The Indian pharma sector is currently benefiting from global market turmoil, positioning it as a safe haven. Focus remains on USFDA approvals, product pipelines, and managing pricing pressures.

buy
Bullish+7590%
5 factsZYDUSLIFE
Maintain a bullish bias on select Indian pharma stocks, particularly those with strong R&D and global market presence, with disciplined risk management.
et_companies22 days ago

Sakar Healthcare partners with Zydus Lifesciences for GCC Markets

The broader market has seen mixed signals recently, with the Nifty hovering around 23,700. However, the pharmaceutical sector often shows resilience and growth driven by specific company-level developments and global demand.

buy
Bullish+6590%
5 factsZYDUSLIFE
Given the positive news for the pharmaceutical sector, traders could look for long opportunities in Zydus Lifesciences (ZYDUSLIFE) and other Indian pharma companies with strong international expansion strategies, maintaining strict stop-losses.

Latest healthcare Topic Coverage

et_companies22 days ago+40

Kerala’s healthcare gold rush: How private equity is reshaping hospitals and raising fears over costs

5 factsHealthcareHospitals
Maintain a neutral to slightly bullish bias on established hospital chains, looking for strategic expansion news, but be cautious of potential regulatory headwinds on pricing.
et_markets24 days ago+40

Deepa Jewellers, Cotec Healthcare receive Sebi approval for IPOs

5 factsJewelleryPharmaceuticals
Maintain a bullish bias on the pharma sector, focusing on companies with strong CDMO capabilities and robust pipelines, while exercising caution on IPO valuations.
et_markets24 days ago+60

10 largecap stocks withsteady rise insales over 4 quarters

5 factsAutomobilesConsumer Discretionary
Given the focus on consistent sales growth, traders should look for large-cap stocks with strong balance sheets and proven management, considering long positions with appropriate risk management.
et_companies24 days ago+70

Invisalign maker Align Technology to invest Rs 1,800 crore in Hyderabad plant

buy5 factsMEDANTAmetalshealthcare
Positive bias for companies involved in medical device manufacturing, contract manufacturing, and the broader healthcare sector.
et_markets24 days ago+75

Apollo Hospitals among 5 stocks hitting 52-week highs; rally up to 15% in a month

buy5 factsGRASIMVBLMOTHERSONDiversifiedBeverages
Consider a 'buy on dips' strategy for fundamentally strong stocks within these performing sectors, maintaining strict stop-losses.
et_markets24 days ago+66.6

Bernstein initiates coverage on 6 pharma stocks, cites 3 major tailwinds for healthcare sector

buy5 factsZYDUSLIFESUNPHARMAPharmaceuticalsHealthcare
Maintain a bullish bias on select Indian pharma stocks, focusing on companies with robust R&D pipelines and strong compliance records, with strict stop-losses.|Quick check: ZYDUSLIFE bullish bias (overbought), SUNPHARMA bullish bias (+0.3% 1d).
et_markets24 days ago+26.8

Bank Nifty near key resistance zone; breakout above 54,300 crucial: Ajit Mishra

5 factsBankingFinancial Services
Maintain a neutral to slightly bullish bias on banking stocks if Bank Nifty sustains above 54,300; otherwise, consider range-bound strategies with strict stop-losses.|Quick check: NIFTY neutral (+0.0% 1d), HDFCBANK bearish bias (oversold).
et_economy24 days ago+30.6

More accurate data soon: Big missing link in India's economy dashboard finally gets set to go live

5 factsfinancial servicesIT services
Neutral to slightly positive for service sector stocks; watch for initial ISP data releases for directional cues.|Quick check: TATASTEEL neutral (+0.8% 1d), HINDALCO bullish bias (+1.4% 1d).
et_companies25 days ago+52.2

Eli Lilly’s obesity drug shows up to 30% weight loss in trial

5 factsPharmaceuticalsHealthcare
Maintain a bullish bias on Indian pharma leaders with strong R&D and manufacturing capabilities, looking for long-term growth opportunities in the metabolic disorder segment.|Quick check: SUNPHARMA bullish bias (+0.3% 1d), CIPLA neutral (-0.2% 1d).
et_markets25 days ago+61.6

Max Healthcare Q4 results: Cons PAT grows 7% YoY to Rs 342 crore, revenue rises 12%

buy5 factsMAXHEALTHHealthcareHospitals & Diagnostic Services
Maintain a bullish bias on quality healthcare stocks, focusing on companies with strong balance sheets and consistent growth in patient volumes and ARPOB.|Quick check: MAXHEALTH bullish bias (overbought), MARUTI bearish bias (oversold).
livemint_markets25 days ago+49.7

Q-Line Biotech IPO Day 1: Issue subscribed over 2x, NIIs steal the show. Check GMP, issue details

hold5 factsBiotechnologyHealthcare
Given the positive IPO sentiment, traders might look for opportunities in other healthcare/biotech IPOs or recently listed companies in these sectors, maintaining strict risk management on listing day volatility.|Quick check: TATASTEEL bearish bias (-0.9% 1d), HINDALCO bullish bias (+3.5% 1d).
livemint_markets25 days ago+76.1

Gland Pharma to Biocon: Pharma stocks rally up to 27% in a month: Can they shield portfolio from US-Iran war-led risks?

buy5 factsGLANDBIOCONMANKINDPharmaceuticalsHealthcare
Maintain a bullish bias on select pharma stocks with strong fundamentals and pipeline, using a stop-loss below recent support levels.|Quick check: GLAND bullish bias (overbought), BIOCON bullish bias (overbought).
et_markets25 days ago+17.3

Last date to buy L&T, 10 other stocks for dividends. Do you own any?

sell5 factsLTHAVELLSSULACapital GoodsConsumer Durables
For dividend capture, buy today and be prepared for the ex-dividend price adjustment tomorrow; for short-term trading, look for potential volatility and volume spikes in these specific stocks today, with a clear exit strategy.|Quick check: LT neutral (-0.4% 1d), HAVELLS bearish bias (-0.1% 1d).
et_markets25 days ago+44

Lenskart shares rise 2% after Q4 profit slips; revenue jumps 46% YoY

5 factsRetailHealthcare
Focus on companies demonstrating strong top-line growth and market expansion, even if short-term profitability is volatile, as this often signals future market leadership. Maintain a long bias on such growth-oriented consumer stocks.|Quick check: MARUTI bearish bias (-0.0% 1d), TATAMOTORS bullish bias (-0.4% 1d).
et_companies26 days ago+60.4

Cloudnine to acquire Apollo’s maternity chain Cradle

hold5 factsAPOLLOHOSPHealthcareHospitals & Allied Services
Maintain a bullish bias on healthcare stocks with strong balance sheets and strategic growth initiatives; consider long positions in APOLLOHOSP.|Quick check: APOLLOHOSP bullish bias (overbought), TCS bearish bias (-0.3% 1d).
livemint_companies26 days ago+69.9

Apollo Hospitals bets on expansion, clinical edge to maintain lead

buy5 factsAPOLLOHOSPHealthcareHospitals & Diagnostics
Maintain a bullish bias on established hospital chains with strong balance sheets and clear expansion strategies, focusing on long-term growth potential.|Quick check: APOLLOHOSP bullish bias (overbought), SUNPHARMA bullish bias (-0.1% 1d).
et_companies26 days ago+6.9

No Ebola case in India yet, centre reviews preparedness after WHO declares global health emergency

5 factshealthcarepharmaceuticals
Neutral to slightly positive long-term bias for healthcare and pharma, contingent on actual government spending.|Quick check: MARUTI bearish bias (-0.0% 1d), TATAMOTORS bullish bias (-0.4% 1d).
livemint_companies26 days ago+6.9

Meta layoff: Here is what 8,000 employees let go will receive as severance package

5 factsauto
Neutral to mildly cautious for Indian IT services, watch client spending.|Quick check: MARUTI bearish bias (-0.0% 1d), TATAMOTORS bullish bias (-0.4% 1d).
et_markets26 days ago+59.4

Apollo Hospitals Q4 Results: Cons PAT jumps 36% YoY to Rs 529 crore, revenue rises 18%; Rs 10 per share dividend declared

hold5 factsAPOLLOHOSPHealthcareHospitals & Allied Services
Maintain a bullish bias on leading hospital stocks, focusing on companies with strong balance sheets and consistent growth. Look for entry points on minor pullbacks.|Quick check: APOLLOHOSP bullish bias (overbought), MARUTI bearish bias (-0.0% 1d).
livemint_markets26 days ago+59.4

Apollo Hospitals Q4 Results: Net profit rises 36% YoY to ₹529 crore, announces final dividend of ₹10 per share

hold5 factsAPOLLOHOSPHealthcareHospitals & Allied Services
Consider a long position in APOLLOHOSP, with a stop-loss below recent support levels, targeting further upside based on strong fundamentals.|Quick check: APOLLOHOSP bullish bias (overbought), MARUTI bearish bias (-0.0% 1d).
livemint_companies26 days ago+56.6

At 100, the Bajaj Group is writing a new chapter—on healthcare

hold5 factsBAJAJFINSVBAJFINANCEBAJAJHLDNGHealthcareFinancial Services
Consider a long bias on established healthcare players with strong fundamentals, but be mindful of potential increased competition from new entrants like Bajaj.|Quick check: BAJAJFINSV neutral (+1.6% 1d), BAJFINANCE neutral (-0.3% 1d).
et_markets26 days ago+49.8

Senior living market may surge to $14 billion by 2031 amid changing family structures: Experts

5 factsReal EstateHealthcare
Look for real estate companies announcing new projects or strategic partnerships in the senior living space, indicating a long-term bullish bias for those players.|Quick check: MARUTI bearish bias (-0.1% 1d), TATAMOTORS bullish bias (+2.5% 1d).
et_markets26 days ago+53

Rising bond yields, oil prices keeping markets on edge; selective bets still emerging: Pankaj Pandey

buy5 factsOil & GasPharmaceuticals
Consider a long bias in select pharma stocks with strong pipelines and regulatory compliance, maintaining strict stop-losses.|Quick check: SUNPHARMA bullish bias (-1.1% 1d), CIPLA bullish bias (-1.3% 1d).
livemint_markets26 days ago+70.5

Zydus Lifesciences share price jumps over 6% after Q4 results. Should you buy or sell?

buy5 factsZYDUSLIFEPharmaceuticalsHealthcare
Maintain a bullish bias on Zydus Lifesciences (ZYDUSLIFE) given strong fundamentals and shareholder-friendly actions; consider entry on dips with a stop-loss below recent support levels.|Quick check: ZYDUSLIFE bullish bias (overbought), MARUTI bearish bias (-0.1% 1d).
et_economy26 days ago+34.5

PM Modi courts Norwegian investment in shipping, green transition

5 factsinfrastructurerenewable_energy
Bullish bias for renewable energy, healthcare, and marine-related infrastructure stocks; look for potential beneficiaries.|Quick check: MARUTI bearish bias (-0.1% 1d), TATAMOTORS bullish bias (+2.5% 1d).
livemint_markets26 days ago+62.1

Q4 results 2026: Lenskart to Grasim among companies to declare Q4 results today; check full list here

buy5 factsGRASIMMOTHERSONBOSCHLTDDiversifiedAutomobiles & Auto Components
For auto stocks, look for commentary on volume growth, commodity cost trends, and EV transition plans. Trade with a bias towards companies showing resilience in margins and strong order books, maintaining strict stop-losses.|Quick check: GRASIM neutral (-0.9% 1d), MOTHERSON bullish bias (overbought).
et_companies27 days ago+69.5

Mankind Pharma profit jumps 30% on chronic therapy demand in Q4

buy5 factsMANKINDPharmaceuticalsHealthcare
Maintain a bullish bias on Indian pharma stocks, focusing on companies with strong domestic presence and product pipelines in chronic and consumer health segments, with strict stop-losses.|Quick check: MANKIND bullish bias (-0.1% 1d), SUNPHARMA bullish bias (-1.1% 1d).
et_companies27 days ago+67.1

Zydus Lifesciences to pursue acquisitions in specialty, rare diseases

buy5 factsZYDUSLIFEPharmaceuticalsHealthcare
Given the positive company-specific news against a slightly negative broader market, ZYDUSLIFE could see buying interest. Traders should look for entry points on any dips, with a bullish bias.|Quick check: ZYDUSLIFE bullish bias (overbought), NIFTY neutral.
et_companies27 days ago+40.3

HCG opens new Bengaluru facility with Rs 129 crore investment

sell5 factsHCGHealthcareHospitals & Allied Services
Maintain a bullish bias on specialized healthcare providers like HCG, focusing on companies with clear expansion plans and technological advancements, with a stop-loss below recent support levels.|Quick check: HCG neutral, MARUTI bearish bias (-0.1% 1d).
et_markets27 days ago+43.6

Hospitals and LIC Housing are the best bottom-up bets right now, says Varun Saboo

sell5 factsLICHFLHealthcareFinancial Services
Look for entry points in fundamentally strong hospital stocks and LICHFL on dips, with a long-term accumulation strategy.|Quick check: LICHFL neutral, MARUTI bearish bias (-1.7% 1d).
et_companies27 days ago+28.9

Hearzap to acquire Amplifon India, expand network to 420 hearing care centres

5 factsHealthcare ServicesConsumer Discretionary
Maintain a watchful stance on specialized healthcare service providers; look for strong balance sheets and growth potential in this consolidating sector.|Quick check: NIFTY neutral, SENSEX neutral.
livemint_markets27 days ago+37.2

Stocks to buy: Sagar Doshi suggests Varun Beverages, Max Healthcare, Page Industries shares to buy

buy5 factsVBLMAXHEALTHPAGEINDFast Moving Consumer GoodsHealthcare
Maintain a bearish bias on banking stocks, looking for shorting opportunities or avoiding long positions, while closely monitoring key metrics like NIM and asset quality.|Quick check: VBL bullish bias (+2.1% 1d), MAXHEALTH bullish bias (+0.7% 1d).
et_markets27 days ago+54.6

​IndusInd Bank, Max Health among 10 stocks that saw highest increase in DII holdings in Q4. Do you own any?

hold5 factsINDUSINDBKMAXHEALTHBankingHealthcare
Maintain a bullish bias on quality banking and healthcare stocks, focusing on those with strong DII accumulation, with strict risk management.|Quick check: INDUSINDBK neutral (oversold), MAXHEALTH bullish bias (+0.7% 1d).
et_markets27 days ago-5.6

Apollo Hospital Share Price Live Updates: Apollo Hospital's previous day performance

4 factshealthcare
Neutral; no specific trade setup indicated by this article.|Quick check: MARUTI bearish bias (-1.7% 1d), TATAMOTORS neutral (-1.0% 1d).
et_companies28 days ago+24.9

GSK's Calpol a well-known trademark: High Court

hold5 factsGSKCONSPFIZERpharma
Positive for GSKCONS, reinforcing brand strength and market position.|Quick check: GSKCONS neutral, PFIZER neutral (-0.6% 1d).
et_markets28 days ago+60.2

Medanta expects Noida hospital to turn cash positive within months as expansion drive accelerates

hold5 factsMEDANTAHealthcareHospitals & Healthcare Services
Given the overall market weakness, traders might look for defensive plays. MEDANTA's positive outlook could make it an attractive long candidate, but risk management is crucial due to the broader market sentiment.|Quick check: MEDANTA bullish bias (+0.1% 1d), NIFTY neutral.
livemint_markets28 days ago+33.5

Vinay Rajani of HDFC Sec suggests Oracle Financial Services, Sun Pharma shares to buy

hold5 factsOFSSSUNPHARMANLCINDIAInformation TechnologyPharmaceuticals
Maintain a bullish bias on quality pharma stocks like Sun Pharma, focusing on accumulation during market corrections with strict stop-losses.|Quick check: OFSS neutral (oversold), SUNPHARMA bullish bias (+0.9% 1d).
livemint_markets28 days ago+47

Healthcare stock Cupid shows resilience against the stock market sell-off

hold5 factsCUPIDHealthcareFMCG
Look for healthcare/FMCG stocks with robust earnings growth and defined expansion strategies; consider long positions with a stop-loss below recent support levels.|Quick check: CUPID neutral, MARUTI neutral (+1.0% 1d).
et_markets28 days ago+64.7

Gland Pharma shares jump 11% as Q4 profit soars 97% YoY, co announces Rs 20/share final dividend

buy5 factsGLANDPharmaceuticalsHealthcare
Maintain a bullish bias on quality pharma stocks with strong CDMO exposure, focusing on companies with clear product pipelines and regulatory compliance. Risk management is crucial.|Quick check: GLAND neutral (-2.3% 1d), SUNPHARMA bullish bias (+0.9% 1d).
et_markets28 days ago+7.5

Last date to buy these four stocks for dividends, do you own any?

hold5 factsALICONATISHAYMANINFRAAutomotive AncillariesInformation Technology
Given the broad market sell-off, any dividend capture strategy should be approached with caution, focusing on tight stop-losses and quick exits post-ex-dividend date.|Quick check: ALICON neutral, ATISHAY neutral.
livemint_companies28 days ago+17.2

Meta 20 May layoff: As ‘doomsday’ nears, anxious employees stock up on free snacks, chargers; apply to jobs preemptively

4 factsauto
Slightly bearish bias for Indian IT services stocks due to potential demand headwinds.|Quick check: MARUTI neutral (+1.0% 1d), TATAMOTORS bullish bias (+5.2% 1d).
et_companiesabout 1 month ago+19.6

Athena opens northeast India’s largest integrated psychiatric hospital in Guwahati

5 factsHealthcareHospitals & Allied Services
Maintain a long-term bullish bias on specialized healthcare providers, looking for entry points during broader market corrections, with a focus on companies with strong balance sheets and expansion plans.|Quick check: NIFTY neutral, BANKNIFTY neutral.
et_companiesabout 1 month ago+4.4

Why is healthcare AI stuck in pilot mode? UiPath has a straightforward answer

5 factsHealthcareInformation Technology
This news is not directly related to the auto sector, so no specific trade setup for auto stocks. However, for IT stocks, a long-term bullish bias on companies with strong AI/healthcare integration capabilities is warranted, with disciplined risk management.|Quick check: NIFTY neutral, MARUTI bearish bias (+0.1% 1d).
livemint_marketsabout 1 month ago+28.3

Max Healthcare sets board meeting date to declare Q4 results 2026, final dividend for FY26

buy5 factsMAXHEALTHJUPITERLIFEHealthcare
Maintain a neutral to slightly bullish bias on healthcare stocks, focusing on companies with strong operational performance and clear growth strategies. Look for positive surprises in earnings and dividend announcements.|Quick check: MAXHEALTH bullish bias (overbought), JUPITERLIFE neutral.
et_marketsabout 1 month ago+45.9

620% rally makes Cupid the costliest stock in its category at 197 P/E. Should investors be cautious?

hold5 factsCUPIDHealthcarePharmaceuticals
For Cupid Ltd. (CUPID), the trade setup is bearish; look for shorting opportunities or avoid long positions.|Quick check: CUPID neutral, NIFTY neutral.
et_marketsabout 1 month ago+50.5

​Paytm, Urban Company among 10 companies with highest FII shareholding in Q4. Check full list

hold5 factsPAYTMCARTREDTREDINGTONTechnologyFinancial Services
Focus on individual stock analysis for these FII-favored companies; consider long positions with tight stop-losses, as broader market sentiment remains cautious.|Quick check: PAYTM neutral (+2.2% 1d), CARTREDT neutral.
et_companiesabout 1 month ago+51

Bajaj Group to enter healthcare biz with Rs 2k cr bet in Pune; expand to 7 cities in a decade

hold5 factsBAJAJFINSVAPOLLOHOSPFORTIShealthcarediversified_conglomerates
Positive bias for Bajaj Group entities; neutral to slightly cautious for existing healthcare providers due to new competition.|Quick check: BAJAJFINSV bearish bias (+0.8% 1d), APOLLOHOSP bullish bias (overbought).
et_marketsabout 1 month ago+47

Metropolis Healthcare sees strong Q4 performance driven by specialty and preventive testing push

sell5 factsMETROPOLISDRLALPATHLABTHYROCAREHealthcareDiagnostics
Maintain a bullish bias on diagnostic stocks, focusing on companies with strong balance sheets and a clear strategy for specialized and preventive testing, with strict risk management.|Quick check: METROPOLIS bearish bias (oversold), DRLALPATHLAB neutral.
et_companiesabout 1 month ago+37.3

Roche Pharma launches India’s first 7-minute injectable immunotherapy for lung cancer

5 factsPharmaceuticalsHealthcare
Maintain a bullish bias on Indian pharma stocks with strong R&D pipelines and a focus on high-growth therapeutic areas like oncology, with disciplined risk management.|Quick check: SUNPHARMA bullish bias (-1.1% 1d), CIPLA bullish bias (+2.8% 1d).
et_marketsabout 1 month ago+39.2

Rohit Singhania bets on financials, telecom and healthcare for alpha generation

5 factsFinancialsTelecommunication
Look for accumulation in large-cap telecom stocks like BHARTIARTL, financial majors, and established healthcare companies, with a focus on companies with strong balance sheets and consistent cash flows.|Quick check: BHARTIARTL neutral (+1.1% 1d), RELIANCE bearish bias (oversold).
et_marketsabout 1 month ago+43.5

Earnings are strong, but margin pain is coming; Dharmesh Kant on 3 sectors worth owning now

sell5 factsBHARTIARTLTelecommunicationsDefence
Given the mixed signals, traders should be cautious; focus on auto companies with strong brand loyalty and pricing power, or those with clear EV transition plans, but maintain strict stop-losses.|Quick check: BHARTIARTL neutral (+1.1% 1d), MARUTI bearish bias (-0.6% 1d).
et_companiesabout 1 month ago+56.4

Zydus to buy Assertio for $166.4 million

hold5 factsZYDUSLIFEPharmaceuticalsHealthcare
Consider a long bias for ZYDUSLIFE, looking for confirmation of upward momentum, while maintaining strict risk management given the broader market volatility.|Quick check: ZYDUSLIFE bullish bias (overbought), NIFTY neutral.
et_companiesabout 1 month ago+52

Sakar Healthcare Q4 profit up 91% at Rs 11.02 crore

hold5 factsSAKARPharmaceuticals
Maintain a bullish bias on Sakar Healthcare (SAKAR) given the strong results, with disciplined risk management around potential profit-booking after the initial surge.|Quick check: SAKAR neutral, MARUTI bearish bias (-0.6% 1d).
et_marketsabout 1 month ago-1.8

US Stock Market: US health insurers post best quarterly performance since pandemic era

5 factsHealthcarePharmaceuticals
No direct trade setup for the auto sector based on this news; continue to monitor volume growth and commodity prices.|Quick check: MARUTI bearish bias (-0.6% 1d), TATAMOTORS bearish bias (-0.3% 1d).
livemint_marketsabout 1 month ago+58

Zydus Lifesciences sets board meeting date to consider buyback of shares. Details here

buy5 factsZYDUSLIFEPharmaceuticalsHealthcare
Consider a long position in ZYDUSLIFE with a tight stop-loss, anticipating positive sentiment if the buyback is announced, but be prepared for volatility.|Quick check: ZYDUSLIFE bullish bias (overbought), NIFTY neutral.
livemint_companiesabout 1 month ago+67.1

Cipla bets on fast-growing biosimilars market, to steadily add products: CEO

buy5 factsCIPLADRLBIOCONPharmaceuticalsHealthcare
Maintain a bullish bias on Indian pharma stocks with strong R&D and biosimilar pipelines, with a focus on companies demonstrating successful product launches and regulatory approvals.|Quick check: CIPLA bullish bias (+2.8% 1d), DRL neutral.
et_companiesabout 1 month ago+13.5

Asia Healthcare Holdings appoints three new independent directors

5 factsHealthcare Services
Maintain a positive bias on well-governed healthcare stocks; consider accumulating on dips, with a stop-loss below recent support levels.|Quick check: NIFTY neutral, SENSEX neutral.
livemint_companiesabout 1 month ago+14.5

Beyond the ‘avocado consumer’: How Aarti Gill built a supplement powerhouse

sell5 factsDABURfmcghealthcare
Neutral to positive for FMCG players with strong health & wellness portfolios; look for potential M&A targets.|Quick check: DABUR neutral (-2.6% 1d), HDFCBANK bearish bias (-0.8% 1d).
et_marketsabout 1 month ago+54.8

MSCI rejig: These 4 stocks may see inflows worth $1,381 million after inclusion

5 factsFinancial ServicesInformation Technology
Look for strong candidates for MSCI inclusion; consider long positions with a tight stop-loss below recent support levels, targeting the passive inflow-driven price appreciation.|Quick check: NIFTY neutral, SENSEX neutral.
et_companiesabout 1 month ago+15

Alzheimer's a key part of Eli Lilly's India specialty medicine push, says company's country head Winselow Tucker

5 factsPharmaceuticalsHealthcare
Maintain a neutral to slightly bullish bias on Indian pharma stocks with strong R&D and manufacturing capabilities, focusing on those with potential for global partnerships in specialty segments.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA bearish bias (+0.0% 1d).
et_marketsabout 1 month ago+21.5

Fractal bets big on enterprise AI despite TMT weakness dragging revenue growth

sell5 factsWIPROHCLTECHInformation TechnologyBanking
Consider a long bias on Indian IT stocks with strong AI and digital transformation portfolios, particularly those with significant exposure to banking and life sciences clients, with a focus on companies demonstrating consistent deal wins.|Quick check: WIPRO bearish bias (oversold), HCLTECH bearish bias (oversold).
et_marketsabout 1 month ago-54

Cohance Lifesciences shares slip 7% after Jefferies cuts target price, downgrades on weak Q4

hold5 factsPharmaceuticalsHealthcare
Maintain a bearish bias on Cohance Lifesciences in the short term, with strict stop-losses, given the weak fundamentals and analyst downgrade.|Quick check: NIFTY neutral, SENSEX neutral.
et_marketsabout 1 month ago+22.5

Unique Picks: 6 stocks held by only one MF scheme in April, falling up to 40% in CY26

hold5 factsSATINROSSELLINDBROOKSbanking
Mixed bias; positive for specific outperformers, negative for underperformers. Requires careful stock-specific analysis.|Quick check: SATIN neutral, ROSSELLIND neutral.
et_marketsabout 1 month ago-58.3

Global Markets | Australian shares fall for third day as banks weigh ahead of federal budget

sell5 factsHDFCBANKICICIBANKSBINBankingFinancial Services
Maintain a bearish bias on Indian banking stocks; consider short positions or protective puts, with strict stop-losses above key resistance levels.|Quick check: HDFCBANK bearish bias (-2.0% 1d), ICICIBANK bearish bias (+0.1% 1d).
livemint_marketsabout 1 month ago+50.8

Park Medi World Q4 Results: Firm's net profit jumps 58% YoY to ₹70.9 crore; revenue up 47%

sell5 factsHealthcarePharmaceuticals
Maintain a bullish bias on healthcare stocks demonstrating strong earnings growth; look for entry points on minor pullbacks with strict stop-loss discipline.|Quick check: MARUTI neutral (-1.6% 1d), TATAMOTORS bearish bias (-2.8% 1d).
et_marketsabout 1 month ago+43.3

Fractal Analytics Q4 Results: Profit more than doubles to Rs 116 crore

5 factsInformation TechnologyHealthcare
Maintain a bullish bias on Indian IT companies with strong AI and digital transformation portfolios, focusing on those with diversified revenue streams and global client bases.|Quick check: MARUTI neutral (-1.6% 1d), TATAMOTORS bearish bias (-2.8% 1d).
et_marketsabout 1 month ago+9.5

Quadria-backed Nobel Hygiene said to plan $300 million India IPO

5 factsconsumer discretionaryhealthcare
Neutral to slightly positive for the broader consumer hygiene sector, as a successful IPO could validate valuations.|Quick check: HDFCBANK bearish bias (-2.0% 1d), ICICIBANK bearish bias (+0.1% 1d).
livemint_marketsabout 1 month ago+69.1

Shares to buy or sell: Chandan Taparia of Motilal Oswal recommends three stocks to buy today - 12 May 2026

buy5 factsSUNPHARMAFORTISGRASIMPharmaceuticalsHealthcare
Given the positive analyst sentiment and recent market correction, a 'buy on dips' strategy for quality pharma stocks like SUNPHARMA could be effective, with a bullish bias.|Quick check: SUNPHARMA bullish bias (overbought), FORTIS bullish bias (overbought).
et_marketsabout 1 month ago+30.4

Hyundai Motor among 5 stocks showing bullish RSI upswing

hold5 factsAutomobileCapital Goods
For auto stocks showing bullish RSI signals, consider a long bias with strict stop-losses, targeting short-term momentum plays.|Quick check: NIFTY neutral, MARUTI neutral (-1.6% 1d).
livemint_marketsabout 1 month ago+31.8

Buy or sell: Gift Nifty down, Vaishali Parekh recommends three intraday stocks for today — 12 May 2026

buy5 factsFORTISGOACARBONHealthcareChemicals
Given the bearish broad market sentiment, traders should approach intraday recommendations with caution, focusing on strict stop-losses and quick profit-booking. Look for short-term momentum plays rather than sustained trends.|Quick check: FORTIS bullish bias (overbought), GOACARBON neutral.
livemint_marketsabout 1 month ago+30.6

Raja Venkatraman, MarketSmith recommend five stocks for 12 May

hold5 factsJKLAKSHMIHINDUNILVRFORTISCementFMCG
For these specific stocks, a short-term long bias can be considered, with strict stop-losses given the overall cautious market sentiment.|Quick check: JKLAKSHMI neutral, HINDUNILVR neutral (+1.1% 1d).
et_companiesabout 1 month ago+21.1

Eli Lilly halts India obesity awareness campaign after regulatory scrutiny, seeks rules clarity

5 factsPharmaceuticalsHealthcare
Maintain a neutral to cautious bias on Indian pharma stocks, particularly those with significant marketing spend or new product launches, until regulatory clarity emerges.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA bearish bias (-3.1% 1d).
et_companiesabout 1 month ago+68.7

Manipal Health acquires land, hospital in Mumbai’s Andheri for Rs 495 crore

buy5 factsFORTISAPOLLOHOSPMAXHEALTHHealthcareReal Estate
Maintain a bullish bias on established Indian hospital chains, looking for opportunities to accumulate on price corrections, with a focus on long-term growth potential.|Quick check: FORTIS bullish bias (overbought), APOLLOHOSP bullish bias (overbought).
et_companiesabout 1 month ago+61.2

Lord's Mark Industries Ltd. announces AI-supported Dialysis ecosystem launch

buy5 factsAPOLLOHOSPFORTISpharmahealthcare
Positive bias for companies innovating in medical technology and healthcare services.|Quick check: APOLLOHOSP bullish bias (overbought), FORTIS bullish bias (overbought).
et_economyabout 1 month ago+36.6

US team expected to visit India for next round of trade talks, says official

5 factsInformation TechnologyPharmaceuticals
Maintain a bullish bias on IT stocks, looking for entry points on dips, with a focus on companies with strong US revenue exposure and robust deal wins.|Quick check: TCS bearish bias (oversold), INFY neutral (-0.3% 1d).
et_companiesabout 1 month ago+57.1

Novartis expands India role in global drug development

buy5 factsPharmaceuticalsHealthcare
Maintain a bullish bias on Indian pharma, especially companies with strong R&D pipelines or CRAMS operations, with a focus on long-term growth potential.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (overbought).